Nucleic acid vaccine for preventing HPV (human papilloma virus) infection
A technology of HPV-L1 and nucleotide sequence, which is applied in the field of preventing HPV infection, HPVL1 microcircle DNA vaccine and its preparation, and achieves the effects of low industrial production cost, enhanced immune response, and simple preparation process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Example 1 Preparation of HPV L1 microcircle DNA
[0043] 1. Reagent Preparation
[0044] 1) TB culture solution: 12 g of peptone, 24 g of yeast extract and 4 ml of glycerin were dissolved in 900 ml of water. After the components are dissolved, autoclave. Cool to 60°C, then add 100ml of a mixture of 170mmol / L KH2PO4 and 0.72mol / L K 2HPO4 that has been sterilized by autoclaving or filtered through a 0.22μm membrane, and the mixture is obtained.
[0045] 2) Minicle Induction Mix: Add 4ml of 1M NaOH and 200μl of 20% arabinose to 100ml of LB, mix and filter through a 0.22μm filter membrane.
[0046] 2. Preparation of recombinant microcircle DNA
[0047] 1) Designing and synthesizing the HPV-L1 recombinant fragment of the objective one with BglII and SalI restriction sites added at both ends to obtain the objective gene fragment;
[0048] 2) Digest the above target gene fragment and the ZY781 vector with BglII and SalI at the same time, and clone the target fragment into ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com